Trial Profile
A Phase III Study of AYX1 in Patients who Suffer from Post-Surgical Pain
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 26 Apr 2019
Price :
$35
*
At a glance
- Drugs Brivoligide (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Adynxx
- 22 Apr 2019 According to an Adynxx media release, following completion of milestones related to the phase 2 mastectomy study (CTP 300671), the company can receive an additional award of up to 9 million dollar for this phase 3 study of brivoligide.
- 12 Apr 2018 According to an Adynxx media release, based on results of a phase II study (AYX1; CTP 273421), the company plans to initiate this trial in subjects with high PCS scores.
- 13 Aug 2015 New trial record